TSX:CRONPharmaceuticals
Does Stronger Q1 Profitability And Spinach Vape Gains Change The Bull Case For Cronos Group (TSX:CRON)?
Cronos Group Inc. reported first-quarter 2026 results, with sales of US$58.97 million, revenue of US$45.21 million, and net income of US$13.75 million, all higher than a year earlier.
The quarter highlighted strong international momentum, particularly record revenue in Israel and Canadian gains that lifted the Spinach brand to the top vape market-share position.
We’ll now examine how this stronger profitability and brand traction may influence Cronos Group’s previously outlined investment...